[go: up one dir, main page]

AU2168295A - Monomeric insulin analog formulations - Google Patents

Monomeric insulin analog formulations

Info

Publication number
AU2168295A
AU2168295A AU21682/95A AU2168295A AU2168295A AU 2168295 A AU2168295 A AU 2168295A AU 21682/95 A AU21682/95 A AU 21682/95A AU 2168295 A AU2168295 A AU 2168295A AU 2168295 A AU2168295 A AU 2168295A
Authority
AU
Australia
Prior art keywords
insulin analog
monomeric insulin
analog formulations
formulations
monomeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU21682/95A
Other versions
AU711428B2 (en
Inventor
Michael Rosario De Felippis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/260,633 external-priority patent/US5461031A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2168295A publication Critical patent/AU2168295A/en
Application granted granted Critical
Publication of AU711428B2 publication Critical patent/AU711428B2/en
Priority to AU10083/00A priority Critical patent/AU738101C/en
Priority claimed from AU10083/00A external-priority patent/AU738101C/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU21682/95A 1994-06-16 1995-06-14 Monomeric insulin analog formulations Expired AU711428B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU10083/00A AU738101C (en) 1994-06-16 2000-01-13 Monomeric insulin analog formulations

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/260,633 US5461031A (en) 1994-06-16 1994-06-16 Monomeric insulin analog formulations
US260633 1994-06-16
AU10083/00A AU738101C (en) 1994-06-16 2000-01-13 Monomeric insulin analog formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU10083/00A Division AU738101C (en) 1994-06-16 2000-01-13 Monomeric insulin analog formulations

Publications (2)

Publication Number Publication Date
AU2168295A true AU2168295A (en) 1996-01-04
AU711428B2 AU711428B2 (en) 1999-10-14

Family

ID=32736698

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21682/95A Expired AU711428B2 (en) 1994-06-16 1995-06-14 Monomeric insulin analog formulations

Country Status (1)

Country Link
AU (1) AU711428B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU720300B2 (en) * 1995-03-31 2000-05-25 Eli Lilly And Company Monomeric insulin analog formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705275B1 (en) * 1993-06-21 1999-02-03 Novo Nordisk A/S Asp-b28 insulin crystals

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU720300B2 (en) * 1995-03-31 2000-05-25 Eli Lilly And Company Monomeric insulin analog formulations

Also Published As

Publication number Publication date
AU711428B2 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
AU5381296A (en) Monomeric insulin analog formulations
GB2290294B (en) Monomeric insulin analog formulations
GB2291427B (en) Insulin analog formulations
AU696232B2 (en) Syringe
AU7085594A (en) Syringe
AU3236895A (en) Aspb1 insulin analogs
AU6314496A (en) Insulin
AU2168295A (en) Monomeric insulin analog formulations
AU738101C (en) Monomeric insulin analog formulations
GB2327424B (en) Monomeric insulin analog formulations
AU731636C (en) Insulin analog formulations
AU694501C (en) Insulin analog formulations
HK1015138B (en) Insulin analog formulations
EG26644A (en) Nonomeric insulin analog formulations
AU3885995A (en) Novel medicinal use
AU6933794A (en) Pharmaceutical formulations
AU693819B2 (en) Syringe
AU673835C (en) Medicinal composition comprising TCF-II
HK1006616B (en) Analog retry
AU7989594A (en) Syringe
AU3600195A (en) Syringe
AUPM826994A0 (en) Syringe

Legal Events

Date Code Title Description
CB Opposition filed

Free format text: NOVO NORDISK A/S

CH Opposition withdrawn

Free format text: NOVA NORDISK A/S

FGA Letters patent sealed or granted (standard patent)